1 completed, 1 not yet recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Not yet recruiting 1 |
Follow Palmoplantar Pustulosis (PPP): new trials by email Literature Review of Palmoplantar Pustulosis (PPP) trials Research Report on Palmoplantar Pustulosis (PPP)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tofacitinib Plus Imatinib in Moderate-to-Severe Palmoplantar Pustulosis Tofacitinib, Imatinib, tofacitinib Placebo - Palmoplantar Pustulosis (PPP) | Phase 3 | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 135 | 2026-08-01 | 2026-08-03 |
| Study of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar Pustulosis Risankizumab, Placebo - Palmoplantar Pustulosis (PPP) | Phase 3 | Completed | AbbVie | 119 | 2020-07-20 | 2022-12-05 |
Psoriasis (2)
Skin Diseases (2) · Skin Diseases, Papulosquamous (2) · Skin and Connective Tissue Diseases (2)
Imatinib Mesylate (1) · risankizumab (1) · tofacitinib (1)
AbbVie (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1)
China (1) · Japan (1)